0002-1436Level 3
EMGALITY (galcanezumab-gnlm)
**Product type:** Human Prescription Drug
**Active ingredient:** GALCANEZUMAB
**Strength:** 120 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Eli Lilly and Company
**Marketing category:** BLA (BLA761063)
GET
/api/v1/systems/ndc_fda/nodes/0002-1436Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.